Christine Vannais MD

Christine Vannais is a seasoned professional with over twenty years of experience working in a variety of industries including contract biopharmaceutical development and manufacturing, USDA biological vaccine manufacturing and research, FDA and EU small molecule manufacturing, primary and secondary packaging operations, API potent compound manufacturing, Department of Defense sites, among others.

Christine was announced as Chief Operating Officer of FDB’s North Carolina site on April 1, 2020. Christine joined FDB in 2012 and led the North Carolina Manufacturing Operations team starting in 2014 as part of the Site Leadership Team. In this role she was responsible for the site’s 24/7 manufacturing operations, which include cGMP production in both microbial and mammalian systems. Prior to joining FDB Christine help positions at MERCK Animal Health and Schering Plough Corporation. Christine was a Certified Safety Professional and is a graduate from Colorado State University.